AVERITAS PHARMA - Trademark Details
Status: 734 - Fifth Extension - Granted
Serial Number
88091437
Word Mark
AVERITAS PHARMA
Status
734 - Fifth Extension - Granted
Status Date
2021-11-29
Filing Date
2018-08-24
Mark Drawing
4000 - Standard character mark
Typeset
Published for Opposition Date
2019-04-30
Attorney Name
Law Office Assigned Location Code
M50
Employee Name
OH, WON TEAK
Statements
Disclaimer with Predetermined Text
"PHARMA"
Goods and Services
Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; pharmaceutical preparations for the treatment of inflammation and gout; vaccines; sanitary preparations for medical purposes; dietetic substances to support nutritional balance and/or to treat deficiencies, namely, vitamins, minerals and/or probiotic preparations adapted for medical use; Wound dressings; surgical dressings; bandages, adhesive patches and adhesive tapes for dressings; medical adhesives to bind wounds; bandages, adhesive patches, adhesive tapes and medical adhesives to close wounds, incisions and cuts
Goods and Services
Conducting of training courses in the field of medicine and pharmaceuticals; issuance and publication of books, journals and other communication media in print, electronic form or otherwise, namely, publishing and issuing of books, journals and scientific papers in the field of medicine and pharmaceuticals, especially for pharmaceutical companies, pharmacists, physicians, patients, health insurance companies and their professional associations
Goods and Services
Scientific and technological services and research in the medical and pharmaceutical field, namely, pharmaceutical product development, product development of medical devices, development of healthcare software, development of healthcare informatics and scientific study and research services in the fields of medicine and the prevention, treatment and management of illnesses, diseases and disorders
Pseudo Mark
AVERITAS PHARMACEUTICAL
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2018-09-04
Primary Code
005
International Class
041 - Education; providing of training; entertainment; sporting and cultural activities. - Education; providing of training; entertainment; sporting and cultural activities.
US Class Codes
100, 101, 107
Class Status Code
6 - Active
Class Status Date
2018-09-04
Primary Code
041
International Class
042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services. - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2018-09-04
Primary Code
042
Current Trademark Owners
Party Name
Party Type
20 - Owner at Publication
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Correspondences
Name
Paul C. Llewellyn
Address
Please log in with your Justia account to see this address.
Prior Registrations
| Relationship Type | Reel Number |
| Continuity Child | 88976570 |
Trademark Events
| Event Date | Event Description |
| 2018-08-28 | NEW APPLICATION ENTERED IN TRAM |
| 2018-09-04 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| 2018-12-10 | ASSIGNED TO EXAMINER |
| 2018-12-13 | PRIORITY ACTION WRITTEN |
| 2018-12-13 | PRIORITY ACTION E-MAILED |
| 2018-12-13 | NOTIFICATION OF PRIORITY ACTION E-MAILED |
| 2019-02-13 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 2019-02-13 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 2019-02-14 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 2019-02-28 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 2019-03-22 | ASSIGNED TO LIE |
| 2019-04-10 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 2019-04-30 | PUBLISHED FOR OPPOSITION |
| 2019-04-30 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 2019-06-25 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 2019-12-06 | TEAS EXTENSION RECEIVED |
| 2019-12-10 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 2019-12-05 | TEAS REQUEST TO DIVIDE RECEIVED |
| 2019-12-10 | ITU OFFICE ACTION ISSUED FOR DIVISIONAL REQUEST |
| 2019-12-20 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 2019-12-05 | DIVISIONAL REQUEST RECEIVED |
| 2020-01-14 | DIVISIONAL PROCESSING COMPLETE |
| 2019-12-06 | EXTENSION 1 FILED |
| 2020-01-14 | EXTENSION 1 GRANTED |
| 2020-01-15 | CORRECTED NOA E-MAILED |
| 2020-01-15 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 2020-05-27 | TEAS EXTENSION RECEIVED |
| 2020-05-27 | EXTENSION 2 FILED |
| 2020-05-27 | EXTENSION 2 GRANTED |
| 2020-05-29 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 2020-11-16 | TEAS EXTENSION RECEIVED |
| 2020-11-16 | EXTENSION 3 FILED |
| 2020-11-16 | EXTENSION 3 GRANTED |
| 2020-11-18 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 2021-04-28 | TEAS EXTENSION RECEIVED |
| 2021-04-28 | EXTENSION 4 FILED |
| 2021-04-28 | EXTENSION 4 GRANTED |
| 2021-04-30 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 2021-11-18 | TEAS EXTENSION RECEIVED |
| 2021-11-18 | EXTENSION 5 FILED |
| 2021-11-29 | EXTENSION 5 GRANTED |
| 2021-11-30 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
